Blueprint Medicines SG&A Expense (Quarterly) Analysis

Blueprint Medicines Corp (BPMC)

107.19 +0.19 (+0.18%) USD | NASDAQ | May 03, 16:00

107.20 +0.01 (+0.01%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	79.32M
September 30, 2023	70.74M
June 30, 2023	71.93M
March 31, 2023	70.95M
December 31, 2022	64.02M
September 30, 2022	57.61M
June 30, 2022	58.69M
March 31, 2022	57.06M
December 31, 2021	54.20M
September 30, 2021	49.81M
June 30, 2021	49.29M
March 31, 2021	42.00M
December 31, 2020	42.54M
September 30, 2020	37.38M
June 30, 2020	42.17M
March 31, 2020	35.66M
December 31, 2019	32.26M
September 30, 2019	25.65M
June 30, 2019	21.92M
March 31, 2019	16.55M

Date	Value
December 31, 2018	13.64M
September 30, 2018	12.04M
June 30, 2018	12.33M
March 31, 2018	9.911M
December 31, 2017	8.092M
September 30, 2017	7.378M
June 30, 2017	6.833M
March 31, 2017	5.683M
December 31, 2016	4.991M
September 30, 2016	4.893M
June 30, 2016	4.688M
March 31, 2016	4.646M
December 31, 2015	3.624M
September 30, 2015	4.222M
June 30, 2015	3.84M
March 31, 2015	2.77M
December 31, 2014	2.961M
September 30, 2014	1.921M
June 30, 2014	1.437M
March 31, 2014	1.572M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

21.92M

Minimum

Jun 2019

79.32M

Maximum

Dec 2023

50.69M

Average

49.81M

Median

Sep 2021

SG&A Expense (Quarterly) Benchmarks